Asia Pac IPO & Placement Research, China biotech, Aequitas Research

Ke Yan, CFA, FRM

An inquisitive investment analyst with background in both finance and computing. Covering ECM research, biotech, market data analytics.

Asia Pac IPO & Placement Research, China biotech

Meituan (3690 HK): Forthcoming Punishment Will Benefit Alibaba

Meituan (3690 HK): CEO's Poem, as Response to Authorities' Sweat Shop Warning, Could Be Disaster

Meituan Placement - Might Not Do a Tencent but Low-End Looks Enticing

Battle Lines Drawn As BABA Builds Out First/Last-Mile Capacity; But Who Will Fund 75+ Bn CNY CapEx?

IPOs and Placements coverage across Asia Pacific

Aequitas Research

We cover all listing across the Asia Pacific along with follow-up placements. As of Dec 2020, our team had covered 539 IPOs with a hit rate of 73.5% and 685 placements with a hit rate of 66.8%.

We combine fundamental bottom-up views with our proprietary quantitative framework to provide a holistic coverage across new listings and placements. Our coverage includes pre-IPO notes before the deal is launched, follow-up analysis once the deal is live and post-listing trading analysis as well.

Equity Bottom-Up

<p>Meituan raised USD 10 billion yesterday via a combination of equity placement, convertible bond issue and share placement to its shareholder Tencent (700 HK) (Refer to our colleague <a href="https://www.smartkarma.com/profiles/sumeet-singh" target="_blank" data-smartkarma-citation="accounts:4" rel="noopener">Sumeet Singh</a>'s note on placement<a href="https://www.smartkarma.com/insights/meituan-placement-might-not-do-a-tencent-but-low-end-looks-enticing" target="_blank" rel="noopener"> here</a>). The use of proceeds is for the technology innovation, including the research and development of autonomous delivery vehicles, drones delivery and other cutting-edge technology.</p>
<p>In this note, we look at Meituan's development with respect to the robotic technology to investors some flavor of what Meituan and its related party has done. We believe the robotic technology could become the company's potential long term re-rating catalyst. </p>

Meituan raised USD 10 billion yesterday via a combination of equity placement, convertible bond issue and share placement to its shareholder Tencent (700 HK) (Refer to our colleague Sumeet Singh's note on placement here). The use of proceeds is for the technology innovation, including the research and development of autonomous delivery vehicles, drones delivery and other cutting-edge technology.
In this note, we look at Meituan's development with respect to the robotic technology to investors some flavor of what Meituan and its related party has done. We believe the robotic technology could become the company's potential long term re-rating catalyst. 

Meituan: Why Robotic Technology Is a Sensible Move